Brochure
8 Mar 2019

API product list

JPG 217 kB

Now, we produced API, Finished dosage, Injection and CMO projects. So, our goods had been separated to API, Finished dosage, Injections and some new products. Our goods had been approved by US FDA, EDQM, EU GMP, TGA, and UK MHRA.

Content provided by our supplier

Shandong Xinhua Pharmaceutical (USA) Inc.

  • US
  • 2018
    On CPHI since

Other Content from Shandong Xinhua Pharmaceutical (USA) Inc. (4)

  • Brochure Profile of SHANDONG XINHUA

    Shandong Xinhua is in an leading position in the manufacturing technology and capacity for antipyretics and analgesics in China, also for the drugs of central nervous system, steroids, cardio cerebrovascular system and anti- infection agents. The total capacity of API is more than 35,000mt per year,and  products Analgin, Ibuprofen, Acetylsalicylic Acid, Caffeine and Levodopa are on the top position in the worldwide. Shandong Xinhua is also the key manufacturer for finished dosage formulation in China with the capacity of 10 billion tablets, 1 billion injection units and 200 million capsules per year. 
  • Brochure Introduction of Shandong Xinhua Pharm

    Now, we produced API, Finished dosage, Injection and CMO projects. So, our goods had been separated to API, Finished dosage, Injections and some new products. 
  • Brochure New Product List

    Now, we produced API, Finished dosage, Injection and CMO projects. So, our goods had been separated to API, Finished dosage, Injections and some new products. This year, we wish to develop our Meloxicam, Glimepiride, Prednisolone and etc. 
  • Brochure Finished Dosage Product List

    Now, we produced API, Finished dosage, Injection and CMO projects. So, our goods had been separated to API, Finished dosage, Injections and some new products. Our goods had been approved by US FDA, EDQM, TGA and UK MHRA.